Sexual function after cancer: paying the price of survivorship

References

• Ferlay J, Colombet M, Soerjomataram I. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019;144:1941–53
   PubMed Web of Science ®Google Scholar
• Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2013. 2016 [cited 2019 3/14/2019]; Available from: https://seer.cancer.gov/archive/csr/1975_2013/
   Google Scholar
• Jackson SE, Wardle J, Steptoe A, Fisher A. Sexuality after a cancer diagnosis: a population-based study. Cancer 2016;122:3883–91
   PubMed Web of Science ®Google Scholar
• Krychman ML, Pereira L, Carter J, Amsterdam A. Sexual oncology: sexual health issues in women with cancer. Oncology 2006;71:18–25
   PubMed Web of Science ®Google Scholar
• Ussher JM, Perz J, Gilbert E; Australian Cancer and Sexuality Study Team. Perceived causes and consequences of sexual changes after cancer for women and men: a mixed method study. BMC Cancer 2015;15:268
   PubMed Web of Science ®Google Scholar
• Reese JB, Shelby RA, Keefe FJ, Porter LS, Abernethy AP. Sexual concerns in cancer patients: a comparison of GI and breast cancer patients. Support Care Cancer 2010;18:1179–89
   PubMed Web of Science ®Google Scholar
• Park ER, Bober SL, Campbell EG, Recklitis CJ, Kutner JS, Diller L. General internist communication about sexual function with cancer survivors. J Gen Intern Med 2009;24:407–11
   Web of Science ®Google Scholar
• Reese JB, Sorice K, Beach MC, et al. Patient-provider communication about sexual concerns in cancer: a systematic review. J Cancer Surviv 2017;11:175–88
   PubMed Web of Science ®Google Scholar
• Aygin D, Cengiz H. Life quality of patients who underwent breast reconstruction after prophylactic mastectomy: systematic review. Breast Cancer 2018;25:497–505
   PubMed Web of Science ®Google Scholar
• Jensen PT, Froeding LP. Pelvic radiotherapy and sexual function in women. Transl Androl Urol 2015;4:186–205
   PubMed Web of Science ®Google Scholar
• Krychman ML, Carter J, Aghajanian CA, Dizon DS, Castiel M. Chemotherapy-induced dyspareunia: a case study of vaginal mucositis and pegylated liposomal doxorubicin injection in advanced stage ovarian carcinoma. Gynecol Oncol 2004;93:561–3
   PubMed Web of Science ®Google Scholar
• Faubion SS, Larkin LC, Stuenkel CA, et al. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health. Menopause 2018;25:596–608
   PubMed Web of Science ®Google Scholar
• Schover LR, Baum GP, Fuson LA, Brewster A, Melhem-Bertrandt A. Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors. J Sex Med 2014;11:3102–11
   PubMed Web of Science ®Google Scholar
• Banning M. Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review. Eur J Cancer Care (Engl) 2012;21:10–19
   PubMed Web of Science ®Google Scholar
• Park J, Kim TH, Lee HH, Chung SH, Lee D. Gynecologic complication of chronic graft-versus-host disease: vaginal obstruction. Obstet Gynecol Sci 2013;56:277–80
   PubMedGoogle Scholar
• Burrows LJ, Creasey A, Goldstein AT. The treatment of vulvar lichen sclerosus and female sexual dysfunction. J Sex Med 2011;8:219–22
   PubMed Web of Science ®Google Scholar
• Carmack Taylor CL, Basen-Engquist K, Shinn EH, Bodurka DC. Predictors of sexual functioning in ovarian cancer patients. JCO 2004;22:881–9
   PubMed Web of Science ®Google Scholar
• Ekwall E, Ternestedt BM, Sorbe B. Important aspects of health care for women with gynecologic cancer. Oncol Nurs Forum 2003;30:313–19
   PubMedGoogle Scholar
• Defining Sexual Health: report of a technical consultation on sexual health 28-31 January 2002, Geneva. 2006 [cited 2019 3/14/2019]; Available from: https://www.who.int/reproductivehealth/publications/sexual_health/defining_sexual_health.pdf
   Google Scholar
• Turner D, Adams E, Boulton M, et al. Partners and close family members of long-term cancer survivors: health status, psychosocial well-being and unmet supportive care needs. Psychooncology 2013;22:12–19
   PubMed Web of Science ®Google Scholar
• Financial Toxicity and Cancer Treatment (PDQ)—Health Professional Version. 2018 [cited 2019 3/14/2019]; Available from: https://www.cancer.gov/about-cancer/managing-care/track-care-costs/financial-toxicity-hp-pdq
   Google Scholar
• Barsky Reese J, Porter LS, Regan KR, et al. A randomized pilot trial of a telephone-based couples intervention for physical intimacy and sexual concerns in colorectal cancer. Psychooncology 2014;23:1005–13
   PubMed Web of Science ®Google Scholar
• Punt L. Patient compliance with the use of vaginal dilators following pelvic radiotherapy for a gynaecological cancer. J Radiother Pract 2011;10:13–25
   Google Scholar
• Walker LM, Beck AM, Hampton AJ, Robinson JW. A biopsychosocial approach to sexual recovery after prostate cancer treatment: suggestions for oncology nursing practice. CONJ 2014;24:256–63
   Google Scholar
• Hordern AJ, Street AF. Constructions of sexuality and intimacy after cancer: patient and health professional perspectives. Soc Sci Med 2007;64:1704–18
   PubMed Web of Science ®Google Scholar
• Bober SL, Reese JB, Barbera L, et al. How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer. Curr Opin Support Palliat Care 2016;10:44–54
   PubMed Web of Science ®Google Scholar
• Flynn KE, Reese JB, Jeffery DD, et al. Patient experiences with communication about sex during and after treatment for cancer. Psychooncology 2012;21:594–601
   PubMed Web of Science ®Google Scholar
• Goldfarb S, Mulhall J, Nelson C, Kelvin J, Dickler M, Carter J. Sexual and reproductive health in cancer survivors. Semin Oncol 2013;40:726–44
   PubMed Web of Science ®Google Scholar
• Rullo JE, Lorenz T, Ziegelmann MJ, et al. Genital vibration for sexual function and enhancement: best practice recommendations for choosing and safely using a vibrator. Sexual and Relationship Therapy 2018;33:278–85
   Web of Science ®Google Scholar
• Chen J, Geng L, Song X, Li H, Giordan N, Liao Q. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial. J Sex Med 2013;10:1575–84
   PubMed Web of Science ®Google Scholar
• Mitchell CM, Reed SD, Diem S, et al. Efficacy of vaginal estradiol or vaginal moisturizer vs placebo for treating postmenopausal vulvovaginal symptoms: a randomized clinical trial. JAMA Intern Med 2018;178:681–90
   PubMed Web of Science ®Google Scholar
• Ekin M, Yaşar L, Savan K, et al. The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Arch Gynecol Obstet 2011;283:539–43
   PubMed Web of Science ®Google Scholar
• Law E, Kelvin JF, Thom B, et al. Prospective study of vaginal dilator use adherence and efficacy following radiotherapy. Radiother Oncol 2015;116:149–55
   PubMed Web of Science ®Google Scholar
• Rullo JE, Lorenz T, Ziegelmann MJ, et al. Genital vibration for sexual function and enhancement: a review of evidence. Sexual Relationship Therapy 2018;33:263–74
   Web of Science ®Google Scholar
• Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 2013;20:888–902
   PubMed Web of Science ®Google Scholar
• Ofman U, Kingsberg SA, Nelson CJ, Sexual problems and cancer. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott Williams & Wilkins; 2008:2804–15
   Google Scholar
• Faubion SS, Shuster LT, Bharucha AE. Recognition and management of nonrelaxing pelvic floor dysfunction. Mayo Clin Proc 2012;87:187–93
   PubMed Web of Science ®Google Scholar
• Tadir Y, Gaspar A, Lev-Sagie A, et al. Light and energy based therapeutics for genitourinary syndrome of menopause: consensus and controversies. Lasers Surg Med 2017;49:137–59
   PubMed Web of Science ®Google Scholar
• Gordon C, Gonzales S, Krychman ML. Rethinking the techno vagina: a case series of patient complications following vaginal laser treatment for atrophy. Menopause 2019;26:423–7
   PubMed Web of Science ®Google Scholar
• Kaunitz AM, Pinkerton JV, Manson JE. Women harmed by vaginal laser for treatment of GSM-the latest casualties of fear and confusion surrounding hormone therapy. Menopause 2019;26:338–40
   PubMed Web of Science ®Google Scholar
• Becorpi A, Campisciano G, Zanotta N, et al. Fractional CO2 laser for genitourinary syndrome of menopause in breast cancer survivors: clinical, immunological, and microbiological aspects. Lasers Med Sci 2018;33:1047–54
   PubMed Web of Science ®Google Scholar
• Pagano T, De Rosa P, Vallone R, et al. Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study. Menopause 2018;25:657–62
   PubMed Web of Science ®Google Scholar
• Bhupathiraju SN, Grodstein F, Stampfer MJ, et al. Vaginal estrogen use and chronic disease risk in the Nurses' Health Study. Menopause 2018 Dec 17. Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Crandall CJ, Hovey KM, Andrews CA, et al. Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study. Menopause 2018;25:11–20
   PubMed Web of Science ®Google Scholar
• Le Ray I, Dell’Aniello S, Bonnetain F, Azoulay L, Suissa S. Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case-control study. Breast Cancer Res Treat 2012;135:603–9
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Committee on Gynecologic Practice. ACOG Committee Opinion No. 659: the use of vaginal estrogen in women with a history of estrogen-dependent breast cancer. Obstet Gynecol 2016;127:e93-6
   PubMed Web of Science ®Google Scholar
• Carter J, Lacchetti C, Andersen BL, et al. Interventions to address sexual problems in people with cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline. JCO 2018;36:492–511
   PubMed Web of Science ®Google Scholar
• Santen RJ, Stuenkel CA, Davis SR, Pinkerton JV, Gompel A, Lumsden MA. Managing menopausal symptoms and associated clinical issues in breast cancer survivors. J Clin Endocrinol Metab 2017;102:3647–61
   PubMed Web of Science ®Google Scholar
• Goetsch MF, Lim JY, Caughey AB. A practical solution for dyspareunia in breast cancer survivors: a randomized controlled trial. JCO 2015;33:3394–400
   PubMedGoogle Scholar
• Althof S, Needle RB. Psychological and Interpersonal dimensions of sexual function and dysfunction. In Sexual Medicine: Sexual Dysfunctions in Men and Women. Paris: Editions 21; 2010
   Google Scholar
• Cella DF, Tross S. Psychological adjustment to survival from Hodgkin's disease. J Consult Clin Psychol 1986;54:616–22
   PubMed Web of Science ®Google Scholar
• Reese JB, Smith KC, Handorf E, et al. A randomized pilot trial of a couple-based intervention addressing sexual concerns for breast cancer survivors. J Psychosoc Oncol 2019;37:242–63
   Web of Science ®Google Scholar
• Brotto LA, Dunkley CR, Breckon E, et al. Integrating quantitative and qualitative methods to evaluate an online psychoeducational program for sexual difficulties in colorectal and gynecologic cancer survivors. J Sex Marital Ther 2017;43:645–62
   PubMed Web of Science ®Google Scholar
• Bober SL, Recklitis CJ, Michaud AL, Wright AA. Improvement in sexual function after ovarian cancer: effects of sexual therapy and rehabilitation after treatment for ovarian cancer. Cancer 2018;124:176–82
   PubMed Web of Science ®Google Scholar